CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A

CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A

Singh, Vijay

Elsevier Science Publishing Co Inc

10/2024

308

Dura

9780443315886

Pré-lançamento - envio 15 a 20 dias após a sua edição

Descrição não disponível.
1. Advances in CRISPR-Cas systems for human diseases
Vijai Singh
2. Advances in CRISPR -Cas systems for human bacterial disease
Indra Mani
3. Advances in CRISPR-Cas systems for gut microbiome
Indra Mani
4. Recent progress in CRISPR -Cas systems for human viral disease
Vijai Singh
5. Recent development in CRISPR -Cas systems for human protozoan diseases
ABHISHEKA BANSAL, Utkarsh Gangwar, Himashree Choudhury and Risha Shameem
6. Advances in CRISPR -Cas systems for fungal infections
Ajay Kumar I
7. Advances in CRISPR-Cas systems based cell and gene therapy
Aparna Jayachandran and Arpita Poddar
8. Advances in CRISPR-Cas systems for epigenetics
Mustafeez Mujtaba Babar, Mahnoor Ilyas, Alvina Gul and Jayakumar Rajadas
9. Current progress in CRISPR -Cas systems for cancer
Mustafeez Mujtaba Babar, Hajra Ali, Hunaiza Fatima, Alvina Gul and Jayakumar Rajadas
10. Current progress in CRISPR -Cas systems for autoimmune diseases
Ajay Kumar I
11. Advances in CRISPR -Cas systems for blood disorders
Deepak balaji Thimiri govindaraj and Mutsa Monica Takundwa
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Human diseases; bacterial disease; gut microbiome editing; viral disease; protozoan disease; fungal disease; stem cell therapy; CRISPR in epigenetics; CRISPR in cancer; and autoimmune disease